NextGen Stars
AACR Annual Meeting 2023 NextGen Stars Program The NextGen Stars program provides an exciting opportunity to increase the visibility...
NextGen Stars
AACR Annual Meeting 2024 NextGen Stars Program The NextGen Stars program provided an exciting opportunity to increase the visibility...
Abstracts
Abstract Presentations The regular abstracts presented at the AACR Annual Meeting 2023 are available for download in PDF, epub,...
Satellite Educational Symposia
AACR Annual Meeting 2023 Satellite Educational Symposia The Satellite Educational Symposia will be held in conjunction with the AACR...
CancerCareers
The 2022 Cancer and Biomedical Research Career was postponed and will take place on Saturday, April 15, 2023, in Orlando,...
Spotlight on Clinical Trials
CLINICAL TRIAL PRESENTations More than 240 clinical trials were presented at the AACR Annual Meeting 2023, including 17 trials...
AACR Runners for Research 5K Run/Walk
Thanks to everyone who participated in the AACR Runners for Research 5K Run/Walk at the AACR Annual Meeting 2023....
Program
Users can search and browse invited speaker sessions and proffered paper sessions through the online program planner. Summaries of...
Schedule at a Glance
The online program planner is now available. Users can search and browse invited speaker sessions. Proffered abstract sessions will...
Supporters
Special Thanks to the Supporters of the AACR Annual Meeting 2023 Cure Level AstraZeneca Bristol Myers Squibb Daiichi Sankyo,...
Deconstructing Peripheral Neuropathy and Chemo Brain
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
Patricia M. LoRusso, DO, PhD (hc), Elected as American Association for Cancer Research President-Elect for 2023-2024
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
AACR Announces Recipients of its 2023 Scientific Achievement Awards, Lectureships, and Prizes
Awardees to be recognized at the AACR Annual Meeting 2023 in Orlando PHILADELPHIA – The American Association for Cancer...
AACR to Recognize Elizabeth M. Jaffee, MD, FAACR, with 2023 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Elizabeth M. Jaffee, MD, Fellow of the AACR...
American Association for Cancer Research Inaugurates New Leadership at the AACR Annual Business Meeting of Members 2023
Philip D. Greenberg, MD, FAACR, Inaugurated as President PHILADELPHIA – The members of the American Association for Cancer Research...
AACR Announces Fellows of the AACR Academy Class of 2023 and New AACR Academy President
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
AACR Announces Recipients for 2023 Distinguished Public Service Awards
PHILADELPHIA – The American Association for Cancer Research (AACR) will present the 2023 AACR Distinguished Public Service Awards for...
Tak W. Mak, PhD, FAACR, Selected for 2023 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research
PHILADELPHIA – The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will...
Carl H. June, MD, FAACR, Honored with 2023 AACR Award for Lifetime Achievement in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Carl H. June, MD, Fellow of the AACR...
AACR Announces Recipients of the 2023 AACR June L. Biedler Prize for Cancer Journalism
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2023 AACR...
E. John Wherry, PhD, Recognized With the 2023 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
PHILADELPHIA – The American Association for Cancer Research (AACR) will award E. John Wherry, PhD, with the 2023 AACR-Cancer...
Andrea Schietinger, PhD, to Present 2023 AACR-Irving Weinstein Foundation Distinguished Lecture
PHILADELPHIA — The American Association for Cancer Research (AACR) will award the 19th AACR-Irving Weinstein Foundation Distinguished Lectureship to...
Olivier Delattre, MD, PhD, Honored with 2023 AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Olivier Delattre, MD, PhD, with the 2023 AACR-St....
Nobel Laureate Carolyn R. Bertozzi, PhD, to Receive 2023 AACR Award for Outstanding Achievement in Chemistry in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Nobel Laureate Carolyn R. Bertozzi, PhD, with the...
Four New Institutions Join AACR Project GENIE® Consortium
PHILADELPHIA — To further its commitment to diversity, equity, and inclusion, the American Association for Cancer Research (AACR) has...
Colorectal Cancer Patients With African Ancestry Had Fewer Clinically Actionable Alterations Than White Patients
ORLANDO, Fla. – Genomic profiling of patients who were treated for colorectal cancer at a major U.S. cancer center...
First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
ORLANDO, Fla. – The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated...
Durvalumab-based Treatment Before and After Surgery Improved Outcomes for Patients With Resectable Non-small Cell Lung Cancer
Patients treated with the durvalumab-based regimen before and after surgery in the AEGEAN trial had a 32% reduction in...
Adjuvant Treatment With Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection in Patients With Liver Cancer
ORLANDO, Fla. – Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma...
Adding a Personalized mRNA Cancer Vaccine to Immunotherapy May Prolong Recurrence-free Survival in Patients With High-risk Melanoma
Clinical benefit was independent of patients’ tumor mutational burden ORLANDO, Fla. – mRNA-4157/V940, a personalized mRNA-based cancer vaccine,...